Drug Pipeline

Calaspargase Pegol Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
14
Active Studies
9
Recruiting
4
Phase 3
7
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-14 NCT05602194
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for…		 overall status: "Recruiting" → "Active Not Recruiting"
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-09 NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
3
Phase 2/3
1
Phase 2
8
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03959085 Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… B Acute Lymphoblastic Leukemia Recruiting
NCT03007147 Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… Acute Lymphoblastic Leukemia Active, Not Recruiting
NCT05602194 Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for… B Acute Lymphoblastic Leukemia Active, Not Recruiting
Phase 2/3
NCT07072585 Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With… Stage II T Lymphoblastic Leukemia/Lymphoma Not Yet Recruiting
Phase 2
NCT06561074 A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined… T-cell Acute Lymphoblastic Leukemia Recruiting
NCT06390319 Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed… T-cell Acute Lymphoblastic Leukemia Recruiting
NCT06533748 Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… Acute Lymphoblastic Leukemia Recruiting
NCT06124157 A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With… B Acute Lymphoblastic Leukemia Recruiting
NCT02981628 Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or… Recurrent B Acute Lymphoblastic Leukemia Recruiting
NCT06317662 Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer… Acute Leukemia of Ambiguous Lineage Recruiting
NCT05761171 A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With… Recurrent Acute Leukemia of Ambiguous Lineage Active, Not Recruiting
NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… Acute Leukemia of Ambiguous Lineage Not Yet Recruiting
Phase 1
NCT05581030 CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia Recruiting
NCT05292664 Venetoclax Basket Trial for High Risk Hematologic Malignancies Myelodysplastic Syndromes, de Novo Recruiting
Sponsors Running Calaspargase Pegol Trials
Children's Oncology Group (6) National Cancer Institute (NCI) (2) St. Jude Children's Research Hospital (2) Andrew E. Place, MD (1) H. Lee Moffitt Cancer Center and Research Institute (1) M.D. Anderson Cancer Center (1) SWOG Cancer Research Network (1)
Disease Areas
Leukemia (14) Acute Lymphoblastic Leukemia (ALL) (14) Acute Myeloid Leukemia (AML) (2) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Calaspargase Pegol trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free